Emerging research suggests that Retatrutide, specifically the 40mg strength, could provide a noteworthy advance in the management of being overweight. Unlike many available therapies, Retatrutide works as a double GIP and GLP-1 agent agonist, potentially causing more substantial weight loss and ass